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Abstract
There is evidence that virtual reality (VR) pain distraction is effective at improving pain-related outcomes.
However, more research is needed to investigate VR environments with other pain-related goals. The main aim of
this study was to compare the differential effects of two VR environments on a set of pain-related and cognitive
variables during a cold pressor experiment. One of these environments aimed to distract attention away from pain
(VRD), whereas the other was designed to enhance pain control (VRC). Participants were 77 psychology students,
who were randomly assigned to one of the following three conditions during the cold pressor experiment: (a)
VRD, (b) VRC, or (c) Non-VR (control condition). Data were collected regarding both pain-related variables
(intensity, tolerance, threshold, time perception, and pain sensitivity range) and cognitive variables (self-efficacy
and catastrophizing). Results showed that in comparison with the control condition, the VRC intervention sig-
nificantly increased pain tolerance, the pain sensitivity range, and the degree of time underestimation. It also
increased self-efficacy in tolerating pain and led to a reduction in reported helplessness. The VRD intervention
significantly increased the pain threshold and pain tolerance in comparison with the control condition, but it did
not affect any of the cognitive variables. Overall, the intervention designed to enhance control seems to have a
greater effect on the cognitive variables assessed. Although these results need to be replicated in further studies,
the findings suggest that the VRC intervention has considerable potential in terms of increasing self-efficacy and
modifying the negative thoughts that commonly accompany pain problems.
Introduction
Research over the last decade has shown that virtualreality (VR) is a useful tool for pain management. In
general terms, VR reduces pain levels, anxiety, unpleasant-
ness, and the need for analgesia, at the same time as in-
creasing the pain threshold, pain tolerance, and procedural
cooperation. Moreover, people enjoy using VR and are keen
to use it again during other painful medical procedures.1–3
The effects of VR have been mainly explained in terms of
pain distraction. Since attentional resources are limited, di-
verting attention away from pain by means of VR leaves
fewer resources available for pain processing.1 This mech-
anism is not new, as distraction is a traditional psychological
intervention for pain that has been shown to possess con-
siderable efficacy.4 However, VR distraction is thought to be
more effective because it is immersive and engaging, inte-
grating many sensory experiences and, therefore, demanding
a greater amount of attention.5
What is not completely clear is whether VR works solely by
drawing attention away from pain. For example, it has been
hypothesized that VR may also work by changing the way in
which people think and perceive reality.6 Being able to identify
mechanisms of action other than pain distraction, or designing
interventions to act specifically on other mechanisms, could
have enormous potential in terms of extending the application
of VR beyond the clinical setting of acute procedural pain
(where most applications have so far been applied7–9). Ap-
plying the strategy of pain distraction in a situation of nonacute
pain outside the clinic is difficult due to the amount of
equipment that is needed. However, if VR has other mecha-
nisms of action (such as changing the way in which people
think), the resulting effects could more easily be extrapolated
outside the healthcare setting, thereby raising the possibility of
developing useful strategies for persistent pain or long-term
pain problems.
Some recent studies have used VR applications for pur-
poses other than pain distraction. For example, Shiri et al.10
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designed a VR system that aimed to reinforce patients with
pain-free virtual images once they achieved an adequate state
of relaxation (as measured by a biofeedback procedure). Re-
sults showed that the VR system improved daily functioning
and quality of life and decreased pain ratings in a sample of
children with chronic headache. In another recent example,
Botella et al.11 combined cognitive behavioral therapy with a
VR environment that sought to develop relaxation and mind-
fulness skills in fibromyalgia patients. Results showed a sig-
nificant reduction in pain and depression, as well as an increase
in positive affect and the use of healthy coping strategies.
In order to explore whether VR might have a mechanism
of action other than pain distraction, we developed and tested
a VR intervention whose aim was to increase pain control.
The intervention involved presenting subjects with a figure
that represented pain and which could be converted into a
figure representing no pain. It was hypothesized that con-
trolling the virtual figure could help people to increase their
sense of pain control. The specific aim of the present study
was to test the effects of this intervention on a set of pain-
related and cognitive variables, comparing the results with
those obtained when using an environment designed for pain
distraction.
Method
Participants
Participants were 77 psychology students at the University of
Barcelona (70 female). Theywere aged between 20 and 56 years
(M=24.06; SD=5.22), and received course credits for taking
part. They were all instructed to refrain from consuming alcohol
or using other drugs on the day prior to the study. The exclusion
criteria were cardiovascular disease, hypertension, metabolic
dysfunctions, pregnancy, Raynaud’s disease, epilepsy, mental
disorder, chronic pain conditions, diseases producing neuro-
pathic pain, or having taken pain/anti-inflammatory medication
during the 4 hours prior to the study.
Apparatus and equipment
Cold pressor apparatus. A plastic tank (34 cm· 34 cm·
16 cm) filled with iced water maintained at 6C (– 1C) was
used for the cold pressor procedure. To ensure that the water
temperature remained constant before each trial, a waterproof
thermometer was attached to the inside of the tank. However,
the temperature could not be seen by the participant. The
range of tolerance achieved with this water temperature was
between 1 3 minutes,12,13 thereby giving participants assigned
to the VR conditions enough time to interact with the VR
environments.
Before each cold water immersion, an additional tank with
warm water (32C) was used for stabilization of hand tem-
perature. A digital thermometer to measure hand temperature
and an atmospheric thermometer to measure room temperature
were used. The room temperature was maintained at 22C.
Hardware. The VR environments were displayed with
two BARCO ID R600 projectors controlled by a computer.
They were projected onto a 2.43 meter· 1.82 meter screen
with a resolution of 1024 · 768 pixels. The distance be-
tween the screen and the participant, who was provided with
StereoGraphics Corp. polarized 3D glasses, was 2 meters.
Software. The VR environments were modeled and ani-
mated with 3D StudioMax 8. Adobe Photoshop 7 was used to
create the different textures. Virtools 3.5 (Educational Ver-
sion) was used to program physical and visual effects, such
that the participant could interact with the VR environment.
Measures
There were five pain-related measures:
Pain threshold. Pain threshold was defined as the number
of seconds of immersion in the cold pressor tank until the
participant reported that the cold sensation first began to feel
painful.
Pain tolerance. Pain tolerance was defined as the total
number of seconds that each participant kept his/her hand
immersed in the cold water.
Pain sensitivity range. Pain sensitivity range (PSR) was
defined as the total number of seconds that passed between
the participant first reporting that the cold sensation had
begun to feel painful (pain threshold) and the point atwhich his/
her hand was withdrawn from the cold water (pain tolerance).
Strongest pain intensity. The strongest pain intensity was
assessed with a visual analog scale (VAS) that consisted of a
line with two anchors: ‘‘no pain’’ and ‘‘the most intense pain.’’
Immediately after withdrawal, participants were asked to rate
the strength of the most intense pain they had felt during the
procedure by making a vertical mark on the point of the line
that they considered representative of their pain. The distance
from the left anchor to the vertical mark served as the pain
rating for the strongest pain intensity.
Estimation of time. Participants were asked to estimate
how long they thought they had had their hand in the water
by the time of withdrawal. The difference between the esti-
mated and real time was calculated.
Two cognitive measures were used:
In vivo pain catastrophizing. This was assessed using the
13-item Pain Catastrophizing Scale (PCS14). Subjects are
asked to reflect on past episodes of pain and to rate using a
5-point scale the frequency of the catastrophic cognitions de-
scribed in each item. Scores can be computed for three sub-
scales: helplessness, rumination, and magnification. Standard
PCS instructions and items were modified slightly in order to
assess catastrophizing cognitions in relation to the cold water
immersion (e.g., by asking subjects to consider statements such
as ‘‘There was nothing I could do to reduce the intensity of the
pain’’ or ‘‘I worried all the time about whether the pain would
end’’). This was done because laboratory-based studies have
highlighted the importance of specifying the context in which
catastrophizing is assessed.15–17 Results in our sample showed
that the internal consistency was high for the in vivo PCS total
score (a= 0.90).
Pain self-efficacy. Based on the work of Bandura et al.,18
pain self-efficacy was assessed through two scales: (a) per-
ceived self-efficacy for tolerating pain, and (b) perceived
self-efficacy for reducing pain intensity. The first of these
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aspects was assessed by asking participants to estimate how
much time they thought they would be able to keep their hand
submerged in the cold water if they had to repeat the immer-
sion. They have to give their answer according to a series of
time categories corresponding to increasing durations of im-
mersion; the categories covered a total range from 0 seconds
to 8 minutes, at 30 second intervals. The second aspect—
self-efficacy for reducing pain intensity—was measured using
a scale that described four severities of pain (ranging from dull
to excruciating). For each severity, participants were required
to rate their perceived ability to reduce pain using a 3-point
scale, ranging from 0= ‘‘limited ability’’ to 2= ‘‘good ability.’’
A total score (ranging from 0 to 8) was then computed, with
higher scores indicating greater perceived self-efficacy in re-
ducing pain. The internal consistency for this scale was ade-
quate in the present sample (a= 0.78).
Procedure
The study was approved by the ethics committee of the
University of Barcelona. A between-subjects experimental
design was used. Subjects participated individually and were
randomly assigned to one of the following experimental
conditions: (a) Non-VR intervention (control condition), (b)
VR distraction intervention, or (c) VR control enhancement
intervention.
Common instructions were initially given to all partici-
pants regarding the cold pressor experiment. The experi-
menter explained to participants that they had to immerse
their nondominant hand in the cold water up to the wrist,
palm-side down, and to leave their hand open (nonfisted).
Participants were instructed to say ‘‘It hurts now’’ when their
hand began to feel uncomfortable or hurt, and ‘‘End’’ when
they decided to withdraw their hand from the water. All
participants were asked to repeat the instructions to confirm
that they had understood them.
Following these common instructions, participants as-
signed to the VR conditions (VR distraction and VR control
enhancement intervention) were provided with stereoscopic
glasses and spent 2–3 minutes learning the possible inter-
actions with the virtual environment. This was done using
their dominant hand to operate the mouse. Subsequently, and
for all participants regardless of their experimental group, the
lights in the room were turned off, with the experimenters
remaining out of sight behind the participant in order to
minimize any influence their presence might have on per-
formance. The cold pressor trial was then immediately
started. For safety reasons, the maximum permitted duration
of immersion was 5 minutes, although participants were
unaware of this. At the end of the trial, participants were
asked to rest their hand on a towel placed on the table. They
were then immediately asked to complete the VAS, the in
vivo PCS, and the pain self-efficacy scales based solely on
their experience during the cold pressor task. The specific
features of each condition were as follows.
Non-VR condition (Non-VR). Participants assigned to the
Non-VR condition were told that during the immersion, they
had to look at a static blank screen in front of them.
VR distraction condition (VRD). To divert the attention of
participants in this condition, a virtual environment called
‘‘Surreal World’’ was used. This was developed on the basis
of surreal art images that were intended to surprise users with
unreal objects that challenge the laws of physics. To improve
the sense of presence in the surreal world, participants were
able to generate simple interactions with the objects (e.g.,
clicking on certain objects will cause them to change or
behave in another way). Participants were asked to navigate
through the environment with one hand while immersing
their other hand in the cold pressor.
VR control enhancement condition (VRC). For this con-
dition, we designed a stereoscopic VR figure as a represen-
tation of pain. The figure, which appeared in the center of the
screen against a black background, was an irregular sharp-
edged polygon that was modelled according to certain sen-
sory descriptors (e.g., burning, cutting, sharp, stabbing, and
stinging) from the McGill Pain Questionnaire.19 The figure
was presented together with an unpleasant sound (a tone of
600Hz at 80 dB). As was explained to participants, the initial
figure and the sound represented an unpleasant pain sensa-
tion, but they could be gradually manipulated to achieve a
pleasant and calm state (analogous to a situation of no pain).
This pleasant state was represented by a spherical figure,
with a certain resemblance to natural scenery, combined with
an audio track produced by a generative music engine, cre-
ating a complex series of quiet environmental sounds.
Participants were asked to try to ameliorate their pain
sensation (caused by the cold pressor) by modifying the vir-
tual figure. To modify the initial stereoscopic figure, subjects
simply had to click on the right button of the mouse. Three
slider controls then appeared on the screen, and these enabled
participants to change the shape and color of the figure, as
well as the sound. They could also rotate the figure and move
it nearer or farther away by clicking and dragging the mouse.
Data analysis
All the analyseswere conducted using SPSS v20.Descriptive
statistics were computed for the different pain-related measures
and the cognitive measures. Between-subjects univariate ana-
lyses of variance (ANOVA) were conducted to test the effects
of the three different conditions (i.e., Non-VR, VRD, andVRC)
on each of the pain-related and cognitive measures. Post hoc
comparisons were carried out to determine the specific differ-
ences between conditions.
Results
Pain-related measures
One-way between-subjects ANOVAs revealed significant
differences between the three conditions for the following
variables: pain threshold, F(2, 74)= 3.56, p< 0.05; pain toler-
ance, F(2, 74)= 9.59, p< 0.0001; pain sensitivity range, F(2,
74)= 4.11, p< 0.05, and estimation of time, F(2, 74)= 3.17,
p< 0.05. There were no statistically significant differences in
relation to pain intensity, F(2, 74)= 0.88, p= 0.41.
Post hoc comparisons (see Table 1) for pain threshold
showed that it was significantly higher in the VRD condition
compared with the Non-VR condition. None of the other
comparisons showed significant differences in terms of pain
threshold. As regards pain tolerance, this was significantly
lower in the Non-VR condition as compared with both the
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VRD and VRC conditions, although there was no significant
difference between the latter two conditions. The pain sensi-
tivity range was significantly broader in the VRC condition in
comparison with the Non-VR condition, but no significant
differences were found for the other comparisons. Similarly,
the underestimation of time was significantly greater in the
VRC condition as compared with the Non-VR condition, but
there were no significant differences for the other comparisons.
Cognitive measures
Statistically significant differences were observed in relation
to self-efficacy for tolerating pain,F(2, 74)= 3.15, p< 0.05, and
on the Helplessness subscale of the PCS, F(2, 74)= 4.62,
p< 0.05. No differences were found for self-efficacy in re-
ducing pain, F(2, 74)= 0.63, p= 0.53; PCS total scores, F(2,
74)= 1.25, p= 0.29; the Rumination subscale, F(2, 74)= 0.353,
p= 0.70; or the Magnification subscale, F(2, 74)= 0.20,
p= 0.81.
Post hoc comparisons revealed that self-efficacy for tol-
erating pain was significantly higher and helplessness ratings
significantly lower during the VRC condition, as compared
with the Non-VR condition. No significant differences
emerged in any of the other comparisons (see Table 2).
Discussion
The aim of the present study was to test whether two
different VR interventions, designed for pain distraction
(VRD) and pain control (VRC), had differential effects on
Table 1. Effects of Interventions on Pain-Related Measures
Non-VR VRD VRC Pairs comparisons [95% CI]
Pain threshold 19.97 (8.94) 70.10 (83.05) 62.12 (84.23) No-VR <VRD* [ - 97.83, - 2.43]
VRD >VRC [ - 37.77, 53.73]
VRC >No-VR (- 5.54O89.85)
Pain tolerance 47.44 (20.76) 145.38 (101.81) 148.74 (114.13) No-VR <VRD** [ - 159.95, - 35.93]
VRD <VRC ( - 62.83O56.12)
VRC >No-VR **(39.29O163.30)
Pain sensitivity 27.46 (19.50) 75.28 (78.64) 86.61 (100.31) No-VR <VRD [- 99.59, 3.97]
VRD <VRC [ - 61.00, 38.33]
VRC >No-VR* (7.36O110.93)
Pain intensity 99.08 (24.36) 95.57 (35.02) 113.25 (75.23) No-VR >VRD [- 31.31, 38.34]
VRD <VRC [ - 38.34, 31.31]
VRC >No-VR (- 20.65O49.00)
Time estimation -4.80 (24.01) -21.92 (110.53) -61.66 (72.70) No-VR >VRD [- 39.42, 72.40]
VRD >VRC [ - 14.91, 95.66]
VRC <No-VR * ( - 112.78O - 0.95)
Data are mean (SD).
*p < 0.05; **p< 0.001.
Table 2. Effects of Interventions on Cognitive Measures Related to Pain
Non-VR VRD VRC Pairs comparisons [95% CI]
Self-efficacy tolerance 58.91 (48.63) 127.69 (175.25) 159.07 (160.07) No-VR <VRD [ - 166.49, 28.93]
VRD <VRC [ - 125.17, 62.41]
VRC >No-VR* (3.30O197.02)
Self-efficacy reduction 3.47 (1.44) 3.59 (1.30) 3.88 (1.31) No-VR <VRD [ - 1.03, 0.80]
VRD <VRC [ - 1.17, 0.58]
VRC >No-VR ( - 0.50O1.32)
Total catastrophism 18.90 (8.09) 15.68 (11.25) 14.52 (9.43) No-VR >VRD [ - 3.59, 10.05]
VRD <VRC [ - 5.44, 7.76]
VRC >No-VR ( - 11.21O2.43)
Helplessness 10.22 (4.53) 7.78 (5.96) 5.75 (4.30) No-VR >VRD [ - 1.12, 6.01]
VRD >VRC [ - 1.45, 5.52]
VRC >No-VR** ( - 8.00O- 0.94)
Rumination 7.45 (2.50) 6.86 (1.89) 7.04 (2.71) No-VR >VRD [ - 1.12, 2.29]
VRD <VRC [ - 2.29, 1.12]
VRC <No-VR ( - 2.10O1.28)
Magnification 2.77 (2.10) 2.43 (2.21) 2.83 (2.44) No-VR >VRD [ - 1.28, 1.96]
VRD <VRC [ - 1.98, 1.19]
VRC >No-VR ( - 1.61O1.73)
Data are mean (SD).
*p < 0.05; **p< 0.001.
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pain-related and cognitive variables. With respect to pain-
related variables, both interventions increased pain toler-
ance. Additionally, the VRC intervention increased the pain
sensitivity range and the degree of time underestimation, as
compared with the control condition. The VRD condition
significantly increased the pain threshold in comparison with
the control condition. Overall, therefore, both interventions
have some effects on pain-related variables, a finding that is
consistent with previous studies1,4 and with our own results in
earlier experiments involving the same interventions.20–22
Notably, however, neither of the two interventions had any
effect on pain intensity. This result might be expected for the
VRC intervention, since its objective is to increase control over
pain, and similar results were obtained when using this envi-
ronment in previous experiments.21,22 However, such a result
is surprising in the case of the VRD intervention, since the
available literature suggests that VR environments designed
for pain distraction reduce pain intensity, this being the effect
that we observed in a previous study that used this environ-
ment.20 These results are likely due, at least in part, to the
sample size used in the present study. However, the fact that
participants were asked to indicate the strongest pain intensity
rather than give an overall rating of pain intensity during the
procedure may also have a bearing on these findings.22
As regards the cognitive variables, an effect on some of
them was only observed for the VRC condition. This sup-
ports our hypotheses as well as the design of the intervention
that aimed to enhance pain control. However, although these
results are quite innovative and interesting, they now need to
be replicated in larger samples, and especially in clinical
contexts.
Assuming that our findings are replicated, an intervention
such as the one presented here would have considerable
potential in terms of extending the benefits of VR beyond the
clinic. Patients would be able to use this VR intervention at
the clinic to gain control over pain and change their cogni-
tions, and this would then help them in their daily life outside
the clinic. A number of reports along these lines have already
been published, one example being experiments involving
VR hypnosis.23,24 In the introduction to this paper, we
mentioned other examples10,11 in which VR has been used
for purposes other than pain distraction, and these could be
particularly useful in the clinical context. What makes the
intervention described here especially interesting and inno-
vative is that it is designed to change cognitive variables (i.e.,
self-efficacy and catastrophizing) that have been shown to be
very important in the context of chronic pain problems.25,26
The main weakness of this study is the use of an unbal-
anced sample regarding gender, since males and females
have different responses to pain,27 and this may influence the
final results. Replications of this study with a more bal-
anced distribution of males and females are needed. Also, in
contrast to previous studies on VRD, this study used non-
immersive VR. The link between immersion and presence
and between pain distraction and presence is well estab-
lished, so this difference may explain the limited efficacy of
VRD in our study. The results obtained in this study showing
that the intervention designed to enhance control (VRC) has
a greater effect on the cognitive variables assessed than the
intervention designed to increase distraction (VRD) can be
applied, at this moment, only to nonimmersive VR systems.
Replications of this study with immersive VR are needed.
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